Published in Am J Clin Pathol on June 01, 2009
Opportunities and challenges for cost-efficient implementation of new point-of-care diagnostics for HIV and tuberculosis. J Infect Dis (2012) 1.82
Global health initiative investments and health systems strengthening: a content analysis of global fund investments. Global Health (2013) 1.60
Molecular epidemiology of simian immunodeficiency virus infection in wild-living gorillas. J Virol (2009) 1.42
Perspectives on introduction and implementation of new point-of-care diagnostic tests. J Infect Dis (2012) 1.33
Strengthening national health laboratories in sub-Saharan Africa: a decade of remarkable progress. Trop Med Int Health (2014) 1.12
Persistent digestive disorders in the tropics: causative infectious pathogens and reference diagnostic tests. BMC Infect Dis (2013) 1.11
The Lablite project: a cross-sectional mapping survey of decentralized HIV service provision in Malawi, Uganda and Zimbabwe. BMC Health Serv Res (2014) 1.08
HIV testing in developing countries: what is required? Indian J Med Res (2011) 1.04
Malaria diagnostic capacity in health facilities in Ethiopia. Malar J (2014) 0.95
A pilot external quality assurance study of transfusion screening for HIV, HCV and HBsAG in 12 African countries. Vox Sang (2014) 0.92
Views of health service providers on obstacles to tuberculosis control in Ghana. Infect Dis Poverty (2013) 0.92
Importance of nonenteric protozoan infections in immunocompromised people. Clin Microbiol Rev (2010) 0.92
A simple Chelex protocol for DNA extraction from Anopheles spp. J Vis Exp (2013) 0.90
Field evaluation of a broadly sensitive HIV-1 in-house genotyping assay for use with both plasma and dried blood spot specimens in a resource-limited country. J Clin Microbiol (2012) 0.86
A public health approach to hepatitis C control in low- and middle-income countries. PLoS Med (2015) 0.85
Laboratory challenges conducting international clinical research in resource-limited settings. J Acquir Immune Defic Syndr (2014) 0.79
An innovative educational approach to professional development of medical laboratory scientists in Botswana. Adv Med Educ Pract (2014) 0.78
Ensuring accurate testing for human immunodeficiency virus in Myanmar. Bull World Health Organ (2014) 0.77
Assessing Perceived Challenges to Laboratory Testing at a Malawian Referral Hospital. Am J Trop Med Hyg (2016) 0.75
Improved Specimen-Referral System and Increased Access to Quality Laboratory Services in Ethiopia: The Role of the Public-Private Partnership. J Infect Dis (2016) 0.75
"This thing of testing our blood is really very important": a qualitative study of primary care laboratory services in Tete Province, Mozambique. Int J Equity Health (2016) 0.75
External quality assessment in resource-limited countries. Biochem Med (Zagreb) (2017) 0.75
The status of medical laboratory towards of AFRO-WHO accreditation process in government and private health facilities in Addis Ababa, Ethiopia. Pan Afr Med J (2015) 0.75
Laboratory support of global health research. J Gen Intern Med (2013) 0.75
Importance of Public-Private Partnerships: Strengthening Laboratory Medicine Systems and Clinical Practice in Africa. J Infect Dis (2016) 0.75
Performance of health laboratories in provision of HIV diagnostic and supportive services in selected districts of Tanzania. BMC Health Serv Res (2017) 0.75
Strengthening the Tuberculosis Specimen Referral Network in Uganda: The Role of Public-Private Partnerships. J Infect Dis (2016) 0.75
Increased utilisation of PEPFAR-supported laboratory services by non-HIV patents in Tanzania. Afr J Lab Med (2016) 0.75
The Role of Laboratory Supervision in Improving the Quality of Malaria Diagnosis: A Pilot Study in Huambo, Angola. Am J Trop Med Hyg (2015) 0.75
Health-care worker engagement in HIV-related quality improvement in Dar es Salaam, Tanzania. Int J Qual Health Care (2011) 0.75
Optimising the laboratory supply chain: The key to effective laboratory services. Afr J Lab Med (2014) 0.75
Translating a National Laboratory Strategic Plan into action through SLMTA in a district hospital laboratory in Botswana. Afr J Lab Med (2014) 0.75
Weighing the costs: Implementing the SLMTA programme in Zimbabwe using internal versus external facilitators. Afr J Lab Med (2014) 0.75
Proficiency testing for HIV, tuberculosis and malaria diagnosis in clinical laboratories in Nigeria. Afr J Lab Med (2014) 0.75
Evaluating turnaround times for early infant diagnosis samples in Kenya from 2011-2014: A retrospective analysis of HITSystem program data. PLoS One (2017) 0.75
Driving hospital transformation with SLMTA in a regional hospital in Cameroon. Afr J Lab Med (2014) 0.75
Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med (2009) 28.62
The World Health Organization African region laboratory accreditation process: improving the quality of laboratory systems in the African region. Am J Clin Pathol (2010) 3.83
Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection. PLoS One (2012) 3.69
Improving quality management systems of laboratories in developing countries: an innovative training approach to accelerate laboratory accreditation. Am J Clin Pathol (2010) 3.52
Integrating prevention of mother-to-child HIV transmission into routine antenatal care: the key to program expansion in Cameroon. J Acquir Immune Defic Syndr (2005) 2.55
Strengthening public health surveillance and response using the health systems strengthening agenda in developing countries. BMC Public Health (2010) 2.41
Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies. PLoS One (2012) 2.41
Central nervous system viral invasion and inflammation during acute HIV infection. J Infect Dis (2012) 2.37
Laboratory reference values for healthy adults from southern Tanzania. Trop Med Int Health (2008) 2.26
Strengthening laboratory services and systems in resource-poor countries. Am J Clin Pathol (2009) 2.20
Cutting edge: resistance to HIV-1 infection among African female sex workers is associated with inhibitory KIR in the absence of their HLA ligands. J Immunol (2006) 2.06
Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults. J Infect Dis (2004) 2.01
A shifting paradigm in strengthening laboratory health systems for global health: acting now, acting collectively, but acting differently. Am J Clin Pathol (2010) 1.81
Analysis of V2 antibody responses induced in vaccinees in the ALVAC/AIDSVAX HIV-1 vaccine efficacy trial. PLoS One (2013) 1.65
Genetic diversity of HIV in Africa: impact on diagnosis, treatment, vaccine development and trials. AIDS (2003) 1.61
Development of two avidity-based assays to detect recent HIV type 1 seroconversion using a multisubtype gp41 recombinant protein. AIDS Res Hum Retroviruses (2010) 1.53
Field experience in implementing ISO 15189 in Kisumu, Kenya. Am J Clin Pathol (2010) 1.52
Development and application of a broadly sensitive dried-blood-spot-based genotyping assay for global surveillance of HIV-1 drug resistance. J Clin Microbiol (2010) 1.52
Scaling up HIV rapid testing in developing countries: comprehensive approach for implementing quality assurance. Am J Clin Pathol (2010) 1.50
Dried tube specimens: a simple and cost-effective method for preparation of HIV proficiency testing panels and quality control materials for use in resource-limited settings. J Virol Methods (2009) 1.48
Identification of HIV-1 infected infants and young children using real-time RT PCR and dried blood spots from Uganda and Cameroon. J Virol Methods (2007) 1.39
Phage display-derived peptides as therapeutic alternatives to antibodies. Drug Discov Today (2004) 1.37
Safety and immunogenicity of combinations of recombinant subtype E and B human immunodeficiency virus type 1 envelope glycoprotein 120 vaccines in healthy Thai adults. J Infect Dis (2003) 1.33
Comparative analysis of HIV-1 viral load assays on subtype quantification: Bayer Versant HIV-1 RNA 3.0 versus Roche Amplicor HIV-1 Monitor version 1.5. J Acquir Immune Defic Syndr (2002) 1.30
HIV-2 protease sequences of subtypes A and B harbor multiple mutations associated with protease inhibitor resistance in HIV-1. AIDS (2004) 1.29
Incidence and characterization of acute HIV-1 infection in a high-risk Thai population. J Acquir Immune Defic Syndr (2008) 1.24
A novel acute HIV infection staging system based on 4th generation immunoassay. Retrovirology (2013) 1.24
CRF06-cpx: a new circulating recombinant form of HIV-1 in West Africa involving subtypes A, G, K, and J. J Acquir Immune Defic Syndr (2002) 1.21
Laboratory equipment maintenance: a critical bottleneck for strengthening health systems in sub-Saharan Africa? J Public Health Policy (2011) 1.20
Virologic and immunologic response to antiretroviral therapy and predictors of HIV type 1 drug resistance in children receiving treatment in Abidjan, Côte d'Ivoire. AIDS Res Hum Retroviruses (2008) 1.17
Laboratory expansion to large-scale international HIV preventive vaccine trials. Curr Opin HIV AIDS (2007) 1.13
A call for randomized controlled trials of antiretroviral therapy for HIV-2 infection in West Africa. AIDS (2008) 1.11
HIV type 1 molecular epidemiology among high-risk clients attending the Thai Red Cross Anonymous Clinic in Bangkok, Thailand. AIDS Res Hum Retroviruses (2010) 1.07
Changes in plasma HIV-1-RNA viral load and CD4 cell counts, and lack of zidovudine resistance among pregnant women receiving short-course zidovudine. AIDS (2002) 1.05
HIV testing in developing countries: what is required? Indian J Med Res (2011) 1.04
Changes in levels of immune activation and reconstitution markers among HIV-1-infected Africans receiving antiretroviral therapy. AIDS (2003) 1.02
Human immunodeficiency virus type 1 group m protease in cameroon: genetic diversity and protease inhibitor mutational features. J Clin Microbiol (2002) 1.01
Evaluation of quantification of HIV-1 RNA viral load in plasma and dried blood spots by use of the semiautomated Cobas Amplicor assay and the fully automated Cobas Ampliprep/TaqMan assay, version 2.0, in Kisumu, Kenya. J Clin Microbiol (2013) 1.01
Performance of drug-resistance genotypic assays among HIV-1 infected patients with predominantly CRF02_AG strains of HIV-1 in Abidjan, Cote d'Ivoire. J Clin Virol (2005) 0.97
Quantification of HIV-1 p24 by a highly improved ELISA: an alternative to HIV-1 RNA based treatment monitoring in patients from Abidjan, Côte d'Ivoire. J Clin Virol (2006) 0.92
Strengthening national laboratory health systems in the Caribbean Region. Glob Public Health (2012) 0.88
HIV-specific T helper responses and frequency of exposure among HIV-exposed seronegative female sex workers in Abidjan, Cote d'Ivoire. J Infect Dis (2004) 0.88
Country leadership and policy are critical factors for implementing laboratory accreditation in developing countries: a study on Uganda. Am J Clin Pathol (2010) 0.87
Positive association between beta-chemokine-producing T cells and HIV type 1 viral load in HIV-infected subjects in Abidjan, Côte d'Ivoire. AIDS Res Hum Retroviruses (2002) 0.86
HIV-1 genetic diversity and compartmentalization in mother/infant pairs infected with CRF01_AE. AIDS (2007) 0.86
Current HIV-2 diagnostic strategy overestimates HIV-2 prevalence in China. J Med Virol (2009) 0.86
Cellular human immunodeficiency virus (HIV)-protective factors: a comparison of HIV-exposed seronegative female sex workers and female blood donors in Abidjan, Côte d'Ivoire. J Infect Dis (2002) 0.86
Surveillance of transmitted HIV type 1 drug resistance in newly diagnosed hiv type 1-infected patients in Shandong Province, China. AIDS Res Hum Retroviruses (2010) 0.85
HIV type 1 drug resistance in adults receiving highly active antiretroviral therapy in Abidjan, Côte d'Ivoire. AIDS Res Hum Retroviruses (2009) 0.84
Low CD4+ T cell counts among African HIV-1 infected subjects with group B KIR haplotypes in the absence of specific inhibitory KIR ligands. PLoS One (2011) 0.83
Virologic and immunologic responses to antiretroviral therapy among HIV-1 and HIV-2 dually infected patients: case reports from Abidjan, Côte d'Ivoire. J Clin Virol (2009) 0.83
Hepatitis C genotype distribution and homology among geographically disparate injecting drug users in Afghanistan. J Med Virol (2013) 0.82
Ensuring quality: a key consideration in scaling-up HIV-related point-of-care testing programs. AIDS (2016) 0.82
Identification of a novel HIV type 1 CRF01_AE cytotoxic T lymphocyte (CTL) epitope restricted by an HLA-Cw0602 allele and a novel HLA-A0206/peptide restriction. AIDS Res Hum Retroviruses (2006) 0.81
Generation of dried tube specimen for HIV-1 viral load proficiency test panels: a cost-effective alternative for external quality assessment programs. J Virol Methods (2012) 0.81
Measurement of HIV-1 CRF02_AG-specific T cell responses indicates the dominance of a p24gag epitope in blood donors in Abidjan, Cote d'Ivoire. J Infect Dis (2005) 0.81
Polymorphism in protease and reverse transcriptase and phenotypic drug resistance of HIV-1 recombinant CRF02_AG isolates from patients with no prior use of antiretroviral drugs in Abidjan, Côte d'Ivoire. J Acquir Immune Defic Syndr (2003) 0.80
Heterosexually acquired CRF01_AE/B recombinant HIV type 1 found in Thailand. AIDS Res Hum Retroviruses (2002) 0.79
Adenovirus-based HIV-1 vaccine candidates tested in efficacy trials elicit CD8+ T cells with limited breadth of HIV-1 inhibition. AIDS (2016) 0.78
HIV type 1 virological response and prevalence of HIV type 1 drug resistance among patients receiving antiretroviral therapy, Shandong, China. AIDS Res Hum Retroviruses (2012) 0.78
Molecular characterization of ambiguous mutations in HIV-1 polymerase gene: implications for monitoring HIV infection status and drug resistance. PLoS One (2013) 0.78
High frequency of HIV-1 and hepatitis C co-infection among young Thai men: evidence for a changing pattern of HIV transmission in Thailand. Southeast Asian J Trop Med Public Health (2003) 0.77
Increasing HIV-1 molecular complexity among men who have sex with men in Bangkok. AIDS Res Hum Retroviruses (2015) 0.77
Two unique recombinant forms identified in incident HIV type 1 infections in Thai blood donors. AIDS Res Hum Retroviruses (2012) 0.76
B cell depletion in HIV-1 subtype A infected Ugandan adults: relationship to CD4 T cell count, viral load and humoral immune responses. PLoS One (2011) 0.76
Field evaluation of the gag-based heteroduplex mobility assay for genetic subtyping of circulating recombinant forms of human immunodeficiency virus type 1 in Abidjan, Côte d'Ivoire. J Clin Microbiol (2003) 0.75
Serum levels of MIP-1beta and RANTES in HIV-1 subtype CRF01_AE infected patients with different rates of disease progression. Southeast Asian J Trop Med Public Health (2008) 0.75
Single-cell level response of HIV-specific and cytomegalovirus-specific CD4 T cells correlate with viral control in chronic HIV-1 subtype A infection. J Acquir Immune Defic Syndr (2012) 0.75
The development of HIV research laboratories in the Royal Thai Army Medical Department. J Med Assoc Thai (2005) 0.75
Implementation science: the laboratory as a command centre. Curr Opin HIV AIDS (2017) 0.75
Improving laboratory efficiencies to scale-up HIV viral load testing. Curr Opin HIV AIDS (2017) 0.75
Use of dried blood spots for HIV-1 genotyping in Southeast Asia: Thailand experience. Southeast Asian J Trop Med Public Health (2012) 0.75